Table 2 Disease Characteristics (N = 102)
Variable | N (%) | |
|---|---|---|
Stage at Diagnosis | Â | |
   Stage I | 12 (11.8%) | |
   Stage II | 33 ( 32.4%) | |
   Stage III | 20 ( 19.6%) | |
   Stage IV | 26 (25.5%) | |
   Unknown | 11 (10.8%) | |
ER Positive | 76 (74.5%) | |
PR Positive | 55 (53.9%) | |
ECOG PS | Â | |
   < 2 | 34 (33.3%) | |
   = 2 | 6 ( 5.9%) | |
   > 2 | 3 (3.0%) | |
   Unknown | 59 ( 57.8%) | |
# Months from initial dx to metastasis (Mean, SD) | 37.9 (42.3) | |
# Months from metastasis to first progression (Mean, SD) a | 13.9 (14.8) | |
Had second disease progression | 78 (76.5%) | |
# Months from 1st to 2nd progression (Mean, SD) | 6.6 (5.4) | |
Deceased Per Medical Record | 45 (44.1%) | |
Metastatic Sites | At initial Metastatic Diagnosis | At First progression |
   Bone | 61 (59.8%) | 67 (65.7%) |
   Brain | 0 (0.0%) | 2 (2.0%) |
   Liver | 27 (26.5%) | 34 (33.3%) |
   Lung | 29 (28.4%) | 36 (35.3%) |
   Peritoneum | 6 (5.9%) | 6 (5.9%) |
   Other | 35 (34.3%) | 44 (43.1%) |
Comorbidities Present (N,%) | Â | |
   Hypertension | 49 (48%) | |
   CHF | 2 (2.0%) | |
   History of MI or Stroke | 4 (3.9%) | |
   Other CVD | 26 (25.5%) | |
   Diabetes | 18 (17.6%) | |